I’m looking to add some FTSE 250 growth stocks to my portfolio of blue-chips and IP Group (LSE: IPO) has caught my eye.
IP Group “invests in breakthrough science and innovation companies”, often university-based research-led companies, which it hopes to help nurture into growth and exit at a profit.
Two examples are portfolio holding Accelercomm, which provides decoding for firms involved in 5G communications, and life sciences company Artios, which develops new therapies for dealing with cancer cells.
Can IP Group keep growing at speed?
Investing in cutting-edge early stage companies is always risky, as impressive intellectual property doesn’t always have commercial teeth. Unsurprisingly, the IP Group share price has been volatile. Its shares are on fire right now. They jumped 21.49% over the last month, at a time when the FTSE 250 fell 0.07%. However, they’re down 21.43% over 12 months. Someone who…
